CSIR’s Anti-Cancer Drug IIIM-290 enters Clinical Trial
Speed Post News Network New Delhi : CSIR constituent lab, CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu, has received Investigational New Drug (IND) approval from New Drugs Division of Central…